BREAKING NEWS
WHY NOT A NEW CAPITAL OF INDIA RATHER THAN NEW BUILDINGS FOR PARLIAMENT AND MINISTRIES
TOURISM - ‘MO BEACH’ CLEANING DRIVE BEGINS IN PURI, MANY ACTOR AND ACTRESS GRACES THE EVENT
SPECIAL VENDOR DEVELOPMENT PROGRAMME FOR SC, ST AND WOMEN MSE AT NTPC KANIHA
NATIONAL - ARMY AIR DEFENCE 6TH ARMY AD REUNION : GOPALPUR
ISRO CHAIRMAN K.SIVAN GRACES THE CONVOCATION OF IIT, BHUBANESWAR AS CHIEF GUEST
GANJAM: MISCREANTS LOOT 7 KG SILVER FROM MAN IN BROAD DAYLIGHT IN KODOLA
DHENKANAL COLLECTORATE RANSACKED BY LAWYERS (?)
CRIME - ODISHA POLICE CRACK NIHARIKA MURDER MYSTERY
CRIME - CRICKET BETTING RACKET BUSTED BY RAYAGADA POLICE
ASK FOR ANUBHABA ODIA MONHLY NEWS MAGAZINE
87% PERCENT SLASH IN PRICES OF ANTI-CANCER DRUGS

87% PERCENT SLASH IN PRICES OF ANTI-CANCER DRUGS Featured

Report;Bureau,Odishabarta 

87% PERCENT SLASH IN PRICES OF ANTI-CANCER DRUGS: LOGIC OF COMPANIES ALLOWED TO MINT MONEY IN PAST: NPPA SHOULD DEVISE PROFIT-FORMULA FOR ALL DRUGS 

New Delhi,20/05/19:It refers to National Pharmaceutical Pricing Authority NPPA slashing prices of nine anti-cancer drugs by upto 87-percent. Big question is firstly why drug-companies were allowed to mint money in past with government-agency like NPPA in existence, and secondly why such price-slashing is not done for all drugs in one go with even World Health Organization WHO establishing that even essential drugs in India with lowest printed Maximum-Retail-Price MRP are exorbitantly priced over manufacturing-cost followed by abnormally high trade-margin between ex-factory price and MRP. High profit-margin is evident from the fact that many companies selling on-line medicines have emerged giving heavy discounts of upto 25-percent on medicines that too bearing heavy cost of packing and home-delivery.

NPPA must devise a profit-formula rather than differentiating by having various categories of medicines where price-regulation is applicable only for some limited drugs. Presently even generic medicines considered to be a cheaper version of respective branded medicines have exorbitant trade-margins of several hundred percent. There are many medicines where different drug-manufacturers take undue advantage of their brand-popularity with prices of same medicine differing several times according to brand-popularity.

Price-revision of any medicines must be allowed only once in a year say on First January only unless approved as special case by NPPA. Gimmick packaging other than in units of 1, 2, 5, 10, 20, 50, 100, 200 and 500 gms, mltrs or units must not be allowed unless approved by NPPA for dose-wise administration. Rule should be to emboss or print name of medicine in a manner that name is there on every capsule or tablet thus ruling out possibility of wastage of drug in case name-portion of strip is consumed.

 

 

Input;Madhu Agarwal

Read 569 times Last modified on Monday, 20 May 2019 04:15
Rate this item
(0 votes)

About Author

Visitor Counter

Today 345

All 131411077

Currently are 110 guests and no members online

X

Right Click

No right click